LIA
BIO icon

LS Investment Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

LS Investment Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-605
Closed -$346K – 229
2021
Q1 		$346K Sell
605
-1,562
-72% -$925K 0.02% 519
2020
Q4 		$1.26M Buy
2,167
+298
+16% +$170K 0.07% 253
2020
Q3 		$963K Buy
1,869
+1,489
+392% +$754K 0.05% 261
2020
Q2 		$172K Sell
380
-143
-27% -$63.1K 0.01% 791
2020
Q1 		$183K Sell
523
-291
-36% -$107K 0.01% 669
2019
Q4 		$301K Buy
814
+123
+18% +$43.4K 0.02% 654
2019
Q3 		$230K Buy
691
+45
+7% +$14.7K 0.01% 720
2019
Q2 		$202K Sell
646
-69
-10% -$20.7K 0.01% 772
2019
Q1 		$219K Sell
715
-696
-49% -$188K 0.01% 754
2018
Q4 		$328K Buy
1,411
+82
+6% +$22K 0.02% 567
2018
Q3 		$416K Sell
1,329
-80
-6% -$24.8K 0.02% 571
2018
Q2 		$407K Buy
1,409
+24
+2% +$6.63K 0.02% 585
2018
Q1 		$346K Sell
1,385
-152
-10% -$38.7K 0.02% 632
2017
Q4 		$367K Sell
1,537
-118
-7% -$28.6K 0.02% 631
2017
Q3 		$368K Sell
1,655
-64
-4% -$14.4K 0.02% 663
2017
Q2 		$389K Buy
1,719
+216
+14% +$47.1K 0.02% 616
2017
Q1 		$300K Sell
1,503
-2
-0.1% -$385 0.02% 686
2016
Q4 		$274K Buy
1,505
+45
+3% +$7.67K 0.02% 675
2016
Q3 		$239K Buy
1,460
+72
+5% +$10.9K 0.02% 685
2016
Q2 		$199K Buy
1,388
+572
+70% +$81.6K 0.01% 760
2016
Q1 		$112K Buy
816
+48
+6% +$6.3K 0.01% 828
2015
Q4 		$106K Hold
768
– – 0.01% 835
2015
Q3 		$103K Sell
768
-16
-2% -$2.3K 0.01% 836
2015
Q2 		$118K Buy
+784
New +$112K 0.01% 819

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LS Investment Advisors's BIO Position: Q2 2021 in Review

LS Investment Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2021, closing a stake of 605 shares — an estimated $346K sold.

LS Investment Advisors first reported a position in BIO in Q2 2015 and held it in 24 quarters. The position peaked at $1.26M in Q4 2020. 509 funds tracked by Wall St. Rank hold BIO as of Q2 2021.

  • LS Investment Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q2 2021 after selling out during the quarter.
  • LS Investment Advisors sold 605 Bio-Rad Laboratories Class A shares in Q2 2021, an estimated $346K.
  • LS Investment Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2015 and held it in 24 quarters.
  • LS Investment Advisors's Bio-Rad Laboratories Class A position peaked at $1.26M in Q4 2020.
  • 509 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2021.

Based on LS Investment Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.